Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

As the cold winter weather sets in, keeping your home warm and energy-efficient becomes a top priority. One of the biggest ...

New Brunswick-based Johnson & Johnson and Bedminster-based Intra-Cellular Therapies, Inc. have entered into a definitive agreement ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

I love a home-focused trade show, whether it’s devoted to kitchen and bath products, designer textiles, or something else ...

Lutron Electronics has introduced Caséta smart shades, expanding its offerings in lighting control and automated shading ...

NEWARK, Del., Jan. 10, 2025 /PRNewswire/ -- MIFA is a leading innovator in the audio industry field and the latest model Yukon will showcase at CES 2025.It is not only just a speaker with exceptional ...

Thanks to these advances, home automation systems can reduce energy bills and help keep your house and belongings safe. Home ...